Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_assertion type Assertion NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_head.
- NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_assertion description "[The SRC-ABL inhibitor bosutinib is one of the five tyrosine kinase inhibitors currently approved for the treatment of Philadelphia chromosome-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_provenance.
- NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_assertion evidence source_evidence_literature NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_provenance.
- NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_assertion SIO_000772 24490604 NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_provenance.
- NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_assertion wasDerivedFrom befree-20150227 NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_provenance.
- NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_assertion wasGeneratedBy ECO_0000203 NP576928.RA-DPr98JCjosJ_eRlERMdKomJ7XZ7-as-ANYSpdtuhkA130_provenance.